Apo-mometasone : Affected Lots May Contain The Presence Of Bacterial Contamination.
APO-MOMETASONE nasal spray products in certain batches may contain bacterial contamination. This recall affects products distributed across Canada. Health authorities have classified this as a Class I recall, which is the most serious category.
- Product
- APO-MOMETASONE
- Reason
- Contamination
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-02-19
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/369fa1aa-ad7e-47d9-953f-c6d7eb2dc430